group (c) is one of 61 small molecule programs targeting Chronic pain. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
193 competitors in Chronic Pain
Zohydro Er
Opana
MS Contin
Cymbalta
Dayvigo
Lamictal
Barhemsys
Bextra
Decadron
Ultram
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details